Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Epistemonikos ID: 634c1d29a3886b47c928c643ad7572914926fb50
First added on: May 20, 2024